BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24870876)

  • 1. Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study.
    Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):12; 14-5. PubMed ID: 24870876
    [No Abstract]   [Full Text] [Related]  

  • 2. Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
    Nowakowski GS; LaPlant B; Habermann TM; Rivera CE; Macon WR; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Klebig RR; Reeder CB; Witzig TE
    Leukemia; 2011 Dec; 25(12):1877-81. PubMed ID: 21720383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
    Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
    Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
    [No Abstract]   [Full Text] [Related]  

  • 5. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
    Gordon LI
    Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP.
    Numata A; Tomita N; Fujimaki K; Tanaka M; Hashimoto C; Oshima R; Matsumoto K; Matsuura S; Yamamoto W; Motomura S; Ishigatsubo Y
    J Clin Exp Hematop; 2012; 52(1):77-9. PubMed ID: 22706536
    [No Abstract]   [Full Text] [Related]  

  • 7. High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.
    Kusano Y; Yokoyama M; Terui Y; Inoue N; Takahashi A; Yamauchi H; Tsuyama N; Nishimura N; Mishima Y; Takeuchi K; Hatake K
    Blood Cancer J; 2017 Sep; 7(9):e614. PubMed ID: 28960192
    [No Abstract]   [Full Text] [Related]  

  • 8. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
    Chan TS; Khong PL; Kwong YL
    Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
    Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
    Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Follicular lymphoma].
    Tomita N
    Nihon Rinsho; 2014 Mar; 72(3):488-92. PubMed ID: 24724409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
    Konishi T; Kanemasa Y; Sasaki Y; Okuya T; Yamaguchi T; Funasaka C; Shimoyama T; Omuro Y
    Hematol Oncol; 2019 Aug; 37(3):303-307. PubMed ID: 30933366
    [No Abstract]   [Full Text] [Related]  

  • 12. CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
    Jäger G; Quehenberger F; Linkesch W; Neumeister P
    Eur J Haematol; 2007 May; 78(5):453-5. PubMed ID: 17419745
    [No Abstract]   [Full Text] [Related]  

  • 13. ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.
    Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U
    Future Oncol; 2016 Jul; 12(13):1553-63. PubMed ID: 27089170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma].
    Oliver C; Guillermo C; Martínez P; Díaz L
    Rev Med Chil; 2013 Jul; 141(7):844-52. PubMed ID: 24356732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
    Palacios Abufón A; Acebo Mariñas E; Gardeazabal García J; García-Ruiz JC
    Actas Dermosifiliogr; 2012 Apr; 103(3):253-5. PubMed ID: 22093542
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
    Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
    Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-CHOP therapy alone for limited-stage follicular lymphoma.
    Tomita N; Suzuki T; Ishiyama Y; Miyashita K; Takahashi H; Numata A; Ito S; Motohashi K; Tachibana T; Takasaki H; Kawasaki R; Hagihara M; Hashimoto C; Yamazaki E; Taguchi J; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
    Leuk Res; 2015 Jun; 39(6):582-5. PubMed ID: 25866096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy for follicular lymphoma revisited: not if, but when?
    Lister TA
    J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
    [No Abstract]   [Full Text] [Related]  

  • 19. R2-CHOP vs R-CHOP for diffuse large B-cell lymphoma.
    Fowler NH
    Clin Adv Hematol Oncol; 2014 Sep; 12(9):608-10. PubMed ID: 25654483
    [No Abstract]   [Full Text] [Related]  

  • 20. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
    McClanahan F; Hielscher T; Rieger M; Hensel M; Bentz M; Schmidt-Wolf I; Käbisch A; Salwender H; Dürk H; Staiger H; Mandel T; Neben K; Hillengass J; Leo E; Krämer A; Ho AD; Witzens-Harig M
    Am J Hematol; 2012 Oct; 87(10):E68-71. PubMed ID: 22847344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.